These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36122840)

  • 1. Evaluation of a rapid, generic human gestational dose model.
    Kapraun DF; Sfeir M; Pearce RG; Davidson-Fritz SE; Lumen A; Dallmann A; Judson RS; Wambaugh JF
    Reprod Toxicol; 2022 Oct; 113():172-188. PubMed ID: 36122840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput PBTK models for
    Breen M; Ring CL; Kreutz A; Goldsmith MR; Wambaugh JF
    Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):903-921. PubMed ID: 34056988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicokinetic Triage for Environmental Chemicals.
    Wambaugh JF; Wetmore BA; Pearce R; Strope C; Goldsmith R; Sluka JP; Sedykh A; Tropsha A; Bosgra S; Shah I; Judson R; Thomas RS; Setzer RW
    Toxicol Sci; 2015 Sep; 147(1):55-67. PubMed ID: 26085347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics.
    Wambaugh JF; Hughes MF; Ring CL; MacMillan DK; Ford J; Fennell TR; Black SR; Snyder RW; Sipes NS; Wetmore BA; Westerhout J; Setzer RW; Pearce RG; Simmons JE; Thomas RS
    Toxicol Sci; 2018 May; 163(1):152-169. PubMed ID: 29385628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.
    Pearce RG; Setzer RW; Davis JL; Wambaugh JF
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):549-565. PubMed ID: 29032447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of physiologically-based toxicokinetic-toxicodynamic (PBTK-TD) model for 4-nonylphenol (4-NP) reflecting physiological changes according to age in males: Application as a new risk assessment tool with a focus on toxicodynamics.
    Jeong SH; Jang JH; Lee YB
    Environ Pollut; 2022 Nov; 312():120041. PubMed ID: 36030954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of semi-generic PBTK modeling for emergency risk assessment after acute inhalation exposure to volatile hazardous chemicals.
    Olie JD; Bessems JG; Clewell HJ; Meulenbelt J; Hunault CC
    Chemosphere; 2015 Aug; 132():47-55. PubMed ID: 25794648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability.
    Ring CL; Pearce RG; Setzer RW; Wetmore BA; Wambaugh JF
    Environ Int; 2017 Sep; 106():105-118. PubMed ID: 28628784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy-specific physiologically-based toxicokinetic models for bisphenol A and bisphenol S.
    Gingrich J; Filipovic D; Conolly R; Bhattacharya S; Veiga-Lopez A
    Environ Int; 2021 Feb; 147():106301. PubMed ID: 33360411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A generic PBTK model implemented in the MCRA platform: Predictive performance and uses in risk assessment of chemicals.
    Tebby C; van der Voet H; de Sousa G; Rorije E; Kumar V; de Boer W; Kruisselbrink JW; Bois FY; Faniband M; Moretto A; Brochot C
    Food Chem Toxicol; 2020 Aug; 142():111440. PubMed ID: 32473292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of the physiologically-based toxicokinetic (PBTK) model for ochratoxin A (OTA) in rats and humans.
    Su BD; Li XM; Huang ZW; Wang Y; Shao J; Xu YY; Shu LX; Li YB
    Ecotoxicol Environ Saf; 2024 May; 276():116277. PubMed ID: 38604061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish Physiologically Based Toxicokinetic Modeling Approach for In Vitro-In Vivo and Cross-Species Extrapolation of Endocrine-Disrupting Chemicals in Risk Assessment.
    Xie R; Xu Y; Ma M; Wang Z
    Environ Sci Technol; 2024 Feb; 58(8):3677-3689. PubMed ID: 38354091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and intercomparison of single and multicompartment physiologically-based toxicokinetic models: Implications for model selection and tiered modeling frameworks.
    Armitage JM; Hughes L; Sangion A; Arnot JA
    Environ Int; 2021 Sep; 154():106557. PubMed ID: 33892222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulating toxicokinetic variability to identify susceptible and highly exposed populations.
    Breen M; Wambaugh JF; Bernstein A; Sfeir M; Ring CL
    J Expo Sci Environ Epidemiol; 2022 Nov; 32(6):855-863. PubMed ID: 36329211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. httk: R Package for High-Throughput Toxicokinetics.
    Pearce RG; Setzer RW; Strope CL; Wambaugh JF; Sipes NS
    J Stat Softw; 2017 Jul; 79(4):1-26. PubMed ID: 30220889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions.
    Honda GS; Pearce RG; Pham LL; Setzer RW; Wetmore BA; Sipes NS; Gilbert J; Franz B; Thomas RS; Wambaugh JF
    PLoS One; 2019; 14(5):e0217564. PubMed ID: 31136631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles.
    Chen CY; Lin Z
    Environ Int; 2024 Apr; 186():108617. PubMed ID: 38599027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches.
    Coecke S; Pelkonen O; Leite SB; Bernauer U; Bessems JG; Bois FY; Gundert-Remy U; Loizou G; Testai E; Zaldívar JM
    Toxicol In Vitro; 2013 Aug; 27(5):1570-7. PubMed ID: 22771339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the in vivo developmental toxicity of fenarimol from in vitro toxicity data using PBTK modelling-facilitated reverse dosimetry approach.
    Bhateria M; Taneja I; Karsauliya K; Sonker AK; Shibata Y; Sato H; Singh SP; Hisaka A
    Toxicol Appl Pharmacol; 2024 Mar; 484():116879. PubMed ID: 38431230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.